Advertisement

Topics

Does Neoadjuvant pCR in Melanoma Predict Better Outcomes?

09:58 EDT 16 Apr 2019 | Medscape

Jeffrey Weber discusses recent trials investigating neoadjuvant combination immunotherapy in patients with melanoma.
Medscape Oncology

Original Article: Does Neoadjuvant pCR in Melanoma Predict Better Outcomes?

NEXT ARTICLE

More From BioPortfolio on "Does Neoadjuvant pCR in Melanoma Predict Better Outcomes?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...